SANOFI — Sanofi India Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapFalling Star

Annual income statement for Sanofi India, fiscal year end - December 31st, INR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	29,566	27,701	19,961	20,132	18,374
Cost of Revenue
Gross Profit	16,253	15,577	10,286	10,158	9,402
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	17,715	19,891	15,490	15,971	13,834
Operating Profit	11,851	7,810	4,471	4,161	4,540
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	12,576	8,643	5,285	4,314	4,447
Provision for Income Taxes
Net Income After Taxes	9,444	6,206	3,646	3,137	3,267
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	9,444	6,206	6,029	4,133	3,267
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	9,444	6,206	6,029	4,133	3,267
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	248	229	153	148	151
Dividends per Share
Special Dividends per Share